To Explore the Influence of Time Factors on Clinical Efficacy of Acupoint Application in Treating Chronic Obstructive Pulmonary Disease
Objective:To observe the duration of the efficacy of acupoint application in the treatment of chronic ob-structive pulmonary disease (COPD) in terms of time factors by retrospectively analyzing the dynamic trend of related indicators at different time points. Methods:Thirty patients with stable COPD who met the criteria and received acu-point application during the three-day period for three consecutive years were selected as the research subjects. August 26,the end of the last day of the dog days,was used as the observation node every year. Pulmonary function tests,COPD Assessment Test (CAT),6-minute walk measurement (6WMT),number of acute exacerbations (N),and dyspnea scale (mMRC) were recorded,and single-factor repeated measures design variance was used for statistical analysis. Results:The main effects of the within-subject factor (time) on FVC,FEV1,CAT score,6WMT,and N were statistically signifi-cant (P<0.05);the main effects of the within-subject factor (time) on FEV1/FVC (％) and mMRC score were not statisti-cally significant (P>0.05). Paired comparisons among the three nodes showed that:there were statistically significant differences in FVC and FEV1 between node 2 and node 1 (P<0.05);there were no statistically significant differences in FEV1/FVC (％),CAT score,6WMT,N,and mMRC score (P>0.05). There were statistically significant differences in CAT score and N between node 2 and node 3 (P<0.05);there were no statistically significant differences in FVC,FEV1,FEV1/FVC (％),6WMT,and mMRC score (P>0.05). There were statistically significant differences in FVC,FEV1,CAT score,6WMT,and N between node 3 and node 1 (P<0.05);there were no statistically significant differences in FEV1/FVC (％) and mMRC score (P>0.05). Conclusion:Acupoint sticking can sustainably change FVC,FEV1,CAT score,6WMT,and N,but has no significant effect on FEV1/FVC (％) and mMRC score. Therefore,acupoint sticking for three consecutive years is sustainable in the treatment of COPD.
万方数据
维普
